Literature DB >> 3943039

The role of fine-needle aspiration biopsy in the rapid diagnosis and management of thyroid neoplasm.

J F Silverman, R L West, E W Larkin, H K Park, J L Finley, M S Swanson, W W Fore.   

Abstract

This report describes our 5-year experience with fine-needle aspiration (FNA) biopsy of the thyroid in a 560-bed teaching hospital. Three hundred nine FNA biopsies were performed primarily by one endocrinologist and interpreted by several pathologists. Analysis of the data reveals the sensitivity of the procedure is 93%, specificity is 95.1%, and the positive and negative predictive values are 88.9% and 96.5%, respectively. This data confirms the diagnostic accuracy of FNA biopsy. Complications were seen in 6 of 309 cases (1.9%) and were relatively mild. Nearly 75% of the cases in the series were cytologically diagnosed as nonneoplastic. Fine-needle aspiration biopsy identified 19.4% of the cases needing surgery, of which 72% had neoplastic nodules, confirming the selection role of the procedure. The management of thyroid nodules is discussed and a selective review of the FNA literature is presented. The authors believe that our experience rebuts the argument that special referral centers are needed to interpret the cytologic material. Several well trained surgical pathologists can become proficient in interpreting the FNA biopsies without significant loss in accuracy, and thereby render a definite diagnosis in the vast majority of the cases. Accordingly, the authors recommend FNA of the thyroid as the initial diagnostic test in the evaluation of thyroid nodules.

Entities:  

Mesh:

Year:  1986        PMID: 3943039     DOI: 10.1002/1097-0142(19860315)57:6<1164::aid-cncr2820570617>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

Review 1.  Use and abuse of frozen section in the diagnosis of follicular thyroid lesions.

Authors:  Virginia A LiVolsi; Zubair W Baloch
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  General surgery: fine-needle aspiration of thyroid nodules.

Authors:  E A Woltering
Journal:  West J Med       Date:  1987-06

3.  Contribution of fine needle aspiration cytology to diagnosis and management of thyroid disease.

Authors:  L Godinho-Matos; G Kocjan; A Kurtz
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

4.  Management options for solitary thyroid nodules in an endemic goitrous area.

Authors:  A K Sarda; A Gupta; P K Jain; S Prasad
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

5.  Fine needle aspiration cytology of thyroid nodules: review of 36 months experience.

Authors:  P Scanlan; M Dowling; P Dervan; T Corrigan; S Heffernan; R Firth
Journal:  Ir J Med Sci       Date:  1993-05       Impact factor: 1.568

6.  Are scintigraphy and ultrasonography necessary before fine-needle aspiration cytology for thyroid nodules?

Authors:  Dilip K Sankhla; Samir S Hussein; Haddia Bererhi; Omeima El Shafie; Nicholas J Woodhouse; V Nirmala
Journal:  J Sci Res Med Sci       Date:  2001-04

7.  Value of quantitative nucleolar features in the preoperative cytological diagnosis of follicular neoplasias of the thyroid.

Authors:  R Montironi; A Braccischi; M Scarpelli; G Matera; R Alberti
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

8.  Management of isolated thyroid swellings: a prospective six year study of fine needle aspiration cytology in diagnosis.

Authors:  E L Cusick; C A MacIntosh; Z H Krukowski; V M Williams; S W Ewen; N A Matheson
Journal:  BMJ       Date:  1990-08-11

9.  Management of nodular goiters and their operative indications.

Authors:  T Kunori; H Shinya; T Satomi; M Abe; S Kawaguchi; H Honda; S Asano
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

10.  Fine-Needle Aspiration Cytology of Papillary Hurthle Cell Carcinoma with Lymphocytic Stroma "Warthin-Like Tumor" of the Thyroid.

Authors:  Zubair W. Baloch; Virginia A. LiVolsi
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.